Research & Analysis
The emergence of alarming and unusual types of resistant bacteria around the world underscores the need for new antibiotics to treat patients with serious and life-threatening infections. Yet there are too few drugs in development to meet anticipated patient needs, and many major pharmaceutical companies have abandoned efforts to develop new antibiotics. Read More
The Food and Drug Administration recently asked Congress for an additional $8 million for its Center for Veterinary Medicine’s Animal Drugs and Feeds Program, including money to enhance the country’s only public health surveillance system for assessing antibiotic resistance in intestinal bacteria found in people, retail meats, and food animals. Read More
Anne Schuchat, M.D., is principal deputy director of the Centers for Disease Control and Prevention. She spoke at length with Pew about the threat of antibiotic resistance and what CDC is doing to combat it. Read More
Support our Work
Invest with Pew to combat antibiotic resistance.